Latest Articles on Lung Cancer
![Non-small cell lung cancer patient Larry Close up image of Non-small cell lung cancer patient Larry](/sites/default/files/2024-06/Non-small%20cell%20lung%20cancer%20patient%20Larry.jpg)
Lung Cancer
Larry’s Story: Advocating for people with lung cancer
In 2013, Larry was diagnosed with non-small cell lung cancer. Learn how his diagnosis led him on a journey of patient advocacy for others with cancer.
Read more
![Optimism Showing an optimistic women who is interacting with another person outside.](/sites/default/files/2024-05/Mental%20well%20being_happy%20woman.png)
Lung Cancer
Breaking prejudice in lung cancer
“Did you smoke?”: Time to rethink the impact of this question on lung cancer patients.
Read more
![DAREON-5 announcement static](/sites/default/files/2023-10/786213422-018_BI_Oncology_DAREON-5%20announcement%20static%201441%20x%20811%20px_CC01%20%282%29.jpg)
Lung Cancer
Our goal of transforming DLL3-positive carcinomas
Our progress in developing a potential targeted immunotherapy for DLL3-positive small cell lung cancer and neuroendocrine carcinomas.
Read more
Related Press Releases
![](/sites/default/files/Images/press-release-holding-image03.jpg)
September 02, 2020
Final analysis of the observational GioTag study: Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
![](/sites/default/files/Images/press-release-holding-image02.jpg)
March 16, 2020
New uncommon EGFR mutations database published featuring clinical outcomes of NSCLC patients treated with afatinib
Links
![inoncology.png](/sites/default/files/2021-12/inoncology.png)
Welcome to InOncology.com
A knowledge hub providing information and education in oncology for healthcare professionals.
Nintedanib (Vargatef) in Oncology
A treatment for adenocarcinoma
Afatinib (Giotrif)
A treatment for EGFR M+ NSCLC
Downloads
Nintedanib in Oncology
Explore nintedanib’s mode of action and role in the treatment of lung cancer (PDF).